RMTI
Rockwell Medical, Inc.
Price Chart
Latest Quote
$0.64
-0.01 (-1.61%)
Current Price
| Previous Close | $0.65 |
| Open | $0.65 |
| Day High | $0.66 |
| Day Low | $0.64 |
| Volume | 223,518 |
Stock Information
| Shares Outstanding | 39.47M |
| Total Debt | $14.39M |
| Cash Equivalents | $23.89M |
| Revenue | $67.68M |
| Net Income | $-5.56M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $25.26M |
| EPS (TTM) | $-0.15 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $15.76M |
| Sales | $67.68M |
| Income | $-5.56M |
| Book/sh | $0.91 |
| Cash/sh | $0.61 |
| Employees | 157 |
Financial Ratios
| Quick Ratio | 3.31 |
| Current Ratio | 3.74 |
| Debt/Eq | 40.13 |
Returns & Margins
| ROA | -5.40% |
| ROE | -16.04% |
| Gross Margin | 17.07% |
| Operating Margin | -8.54% |
| Profit Margin | -7.99% |
Ownership
| Insider Ownership | 12.31% |
| Institutional Ownership | 10.13% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 9.14 |
| PEG | 4.43 |
| P/S | 0.37 |
| P/B | 0.70 |
Analyst Data
| Recommendation | none |
| Target Price | $3.00 |
Technical Indicators
| SMA20 | $0.70 |
| SMA50 | $0.80 |
| SMA200 | $1.00 |
| RSI | 34.37 |
| ATR | 0.0436 |
| Shares Float | 35.26M |
| Short Float | 1.00% |
| Short Ratio | 1.42 |
| Volatility | 1.58 |
| Rel Volume | 0.68 |
Performance History
| Week | +3.23% |
| Month | -20.00% |
| Quarter | -37.86% |
| 6 Months | -22.89% |
| YTD | -25.58% |
| Year | -29.67% |
| 3 Years | -85.35% |
| 5 Years | -94.12% |
| 10 Years | -99.27% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.64 | 223,500 |
| 2026-06-17 | $0.65 | 160,400 |
| 2026-06-16 | $0.68 | 437,200 |
| 2026-06-15 | $0.64 | 122,200 |
| 2026-06-12 | $0.62 | 218,300 |
| 2026-06-11 | $0.62 | 487,400 |
| 2026-06-10 | $0.67 | 426,000 |
| 2026-06-09 | $0.69 | 189,500 |
| 2026-06-08 | $0.66 | 319,600 |
| 2026-06-05 | $0.66 | 421,000 |
| 2026-06-04 | $0.70 | 310,300 |
| 2026-06-03 | $0.68 | 578,000 |
| 2026-06-02 | $0.71 | 780,800 |
| 2026-06-01 | $0.72 | 450,600 |
| 2026-05-29 | $0.74 | 242,200 |
| 2026-05-28 | $0.76 | 212,100 |
| 2026-05-27 | $0.76 | 179,000 |
| 2026-05-26 | $0.76 | 550,100 |
| 2026-05-22 | $0.79 | 131,000 |
| 2026-05-21 | $0.81 | 133,700 |
| 2026-05-20 | $0.82 | 616,500 |
| 2026-05-19 | $0.80 | 95,000 |
About Rockwell Medical, Inc.
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
đ° Latest News
RMTI Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-08T15:11:20Z
Rockwell Medical, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-08T12:30:00Z
Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-07T11:10:03Z
How The Rockwell Medical (RMTI) Story Is Shifting With Recalibrated Fair Value Targets
Simply Wall St. âĸ 2026-04-28T17:04:38Z
Should Value Investors Buy Rockwell Medical (RMTI) Stock?
Zacks âĸ 2026-03-27T13:40:02Z
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
Zacks âĸ 2026-03-27T12:55:01Z
Rockwell Medical Inc (RMTI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
GuruFocus.com âĸ 2026-03-26T19:00:49ZRockwell Medical, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-26T17:14:54Z
Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates
Zacks âĸ 2026-03-26T11:05:02Z
Rockwell Medical: Q4 Earnings Snapshot
Associated Press Finance âĸ 2026-03-26T10:15:10Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $57,563,000 | $84,005,000 | $74,908,000 | $68,733,000 |
| Cost Of Revenue | $57,563,000 | $84,005,000 | $74,908,000 | $68,733,000 |
| Total Revenue | $69,258,000 | $101,489,000 | $83,612,000 | $72,810,000 |
| Operating Revenue | $69,258,000 | $101,489,000 | $83,612,000 | $72,810,000 |
| Expenses | ||||
| Interest Expense | $1,124,000 | $1,254,000 | $2,301,000 | $1,936,000 |
| Total Expenses | $73,949,000 | $100,881,000 | $90,282,000 | $89,590,000 |
| Other Income Expense | $267,000 | $74,000 | $321,000 | $4,000 |
| Net Non Operating Interest Income Expense | $-890,000 | $-1,162,000 | $-2,090,000 | $-1,903,000 |
| Interest Expense Non Operating | $1,124,000 | $1,254,000 | $2,301,000 | $1,936,000 |
| Operating Expense | $16,386,000 | $16,876,000 | $15,374,000 | $20,857,000 |
| Selling And Marketing Expense | $2,354,000 | $2,749,000 | $2,125,000 | $2,094,000 |
| General And Administrative Expense | $14,032,000 | $14,108,000 | $12,142,000 | $15,644,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-5,314,000 | $-480,000 | $-8,439,000 | $-18,679,000 |
| Net Interest Income | $-890,000 | $-1,162,000 | $-2,090,000 | $-1,903,000 |
| Interest Income | $234,000 | $92,000 | $211,000 | $33,000 |
| Normalized Income | $-5,581,000 | $-554,000 | $-8,760,000 | $-18,683,000 |
| Net Income From Continuing And Discontinued Operation | $-5,314,000 | $-480,000 | $-8,439,000 | $-18,679,000 |
| Total Operating Income As Reported | $-4,691,000 | $608,000 | $-6,670,000 | $-16,780,000 |
| Net Income Common Stockholders | $-5,467,000 | $-782,000 | $-8,589,000 | $-18,679,000 |
| Net Income | $-5,314,000 | $-480,000 | $-8,439,000 | $-18,679,000 |
| Net Income Including Noncontrolling Interests | $-5,314,000 | $-480,000 | $-8,439,000 | $-18,679,000 |
| Net Income Continuous Operations | $-5,314,000 | $-480,000 | $-8,439,000 | $-18,679,000 |
| Pretax Income | $-5,314,000 | $-480,000 | $-8,439,000 | $-18,679,000 |
| Interest Income Non Operating | $234,000 | $92,000 | $211,000 | $33,000 |
| Operating Income | $-4,691,000 | $608,000 | $-6,670,000 | $-16,780,000 |
| Gross Profit | $11,695,000 | $17,484,000 | $8,704,000 | $4,077,000 |
| Per Share | ||||
| Diluted EPS | $-0.15 | $-0.03 | $-0.37 | $-1.89 |
| Basic EPS | $-0.15 | $-0.03 | $-0.37 | $-1.89 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,265,000 | $2,880,000 | $-5,015,000 | $-16,171,000 |
| Total Unusual Items | $267,000 | $74,000 | $321,000 | $4,000 |
| Total Unusual Items Excluding Goodwill | $267,000 | $74,000 | $321,000 | $4,000 |
| Reconciled Depreciation | $2,192,000 | $2,180,000 | $1,444,000 | $576,000 |
| EBITDA (Bullshit earnings) | $-1,998,000 | $2,954,000 | $-4,694,000 | $-16,167,000 |
| EBIT | $-4,190,000 | $774,000 | $-6,138,000 | $-16,743,000 |
| Diluted Average Shares | $35,974,231 | $31,058,539 | $23,322,915 | $9,866,844 |
| Basic Average Shares | $35,974,231 | $31,058,539 | $23,322,915 | $9,866,844 |
| Diluted NI Availto Com Stockholders | $-5,467,000 | $-782,000 | $-8,589,000 | $-18,679,000 |
| Otherunder Preferred Stock Dividend | $153,000 | $302,000 | $150,000 | - |
| Gain On Sale Of Security | $267,000 | $74,000 | $321,000 | $4,000 |
| Research And Development | $0 | $19,000 | $1,107,000 | $3,119,000 |
| Selling General And Administration | $16,386,000 | $16,857,000 | $14,267,000 | $17,738,000 |
| Other Gand A | $14,032,000 | $14,108,000 | $12,142,000 | $15,644,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $26,404,000 | $21,458,000 | $9,611,000 | $13,185,000 |
| Total Assets | $57,145,000 | $59,208,000 | $52,173,000 | $46,635,000 |
| Total Non Current Assets | $18,982,000 | $22,178,000 | $23,403,000 | $11,325,000 |
| Other Non Current Assets | $556,000 | $706,000 | $705,000 | $1,799,000 |
| Goodwill And Other Intangible Assets | $10,577,000 | $11,128,000 | $11,680,000 | $921,000 |
| Other Intangible Assets | $9,656,000 | $10,207,000 | $10,759,000 | - |
| Current Assets | $38,163,000 | $37,030,000 | $28,770,000 | $35,310,000 |
| Other Current Assets | $1,599,000 | $1,359,000 | $1,063,000 | $1,745,000 |
| Inventory | $3,424,000 | $5,778,000 | $5,871,000 | $5,814,000 |
| Receivables | $8,143,000 | $8,291,000 | $10,901,000 | $6,259,000 |
| Accounts Receivable | $8,143,000 | $8,291,000 | $10,901,000 | $6,259,000 |
| Cash Cash Equivalents And Short Term Investments | $24,997,000 | $21,602,000 | $10,935,000 | $21,492,000 |
| Cash And Cash Equivalents | $10,711,000 | $15,662,000 | $8,983,000 | $10,102,000 |
| Allowance For Doubtful Accounts Receivable | - | $0 | $-81,000 | $-33,000 |
| Gross Accounts Receivable | - | $8,291,000 | $10,982,000 | $6,292,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Long Term Debt And Capital Lease Obligation | $10,584,000 | $11,102,000 | $11,256,000 | $12,224,000 |
| Long Term Debt | $8,826,000 | $8,472,000 | $8,293,000 | $7,555,000 |
| Current Debt And Capital Lease Obligation | $1,888,000 | $2,433,000 | $2,183,000 | $4,139,000 |
| Current Debt | $264,000 | $268,000 | $244,000 | $2,134,000 |
| Other Current Borrowings | - | - | - | $1,631,000 |
| Net Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $20,164,000 | $26,622,000 | $30,882,000 | $32,529,000 |
| Total Non Current Liabilities Net Minority Interest | $10,584,000 | $12,531,000 | $14,245,000 | $14,838,000 |
| Non Current Deferred Liabilities | $0 | $1,429,000 | $2,975,000 | $2,600,000 |
| Current Liabilities | $9,580,000 | $14,091,000 | $16,637,000 | $17,691,000 |
| Current Deferred Liabilities | $1,356,000 | $2,514,000 | $2,789,000 | $1,797,000 |
| Current Notes Payable | $264,000 | $268,000 | $244,000 | $503,000 |
| Payables And Accrued Expenses | $3,694,000 | $6,224,000 | $8,998,000 | $8,881,000 |
| Payables | $1,999,000 | $2,869,000 | $4,516,000 | $4,053,000 |
| Accounts Payable | $1,999,000 | $2,869,000 | $4,516,000 | $4,053,000 |
| Other Non Current Liabilities | - | - | $14,000 | $14,000 |
| Equity | ||||
| Common Stock Equity | $36,981,000 | $32,586,000 | $21,291,000 | $14,106,000 |
| Total Equity Gross Minority Interest | $36,981,000 | $32,586,000 | $21,291,000 | $14,106,000 |
| Stockholders Equity | $36,981,000 | $32,586,000 | $21,291,000 | $14,106,000 |
| Gains Losses Not Affecting Retained Earnings | $131,000 | $54,000 | $-1,000 | $163,000 |
| Other Equity Adjustments | $131,000 | $54,000 | $-1,000 | $163,000 |
| Retained Earnings | $-402,992,000 | $-397,678,000 | $-397,198,000 | $-388,759,000 |
| Other | ||||
| Ordinary Shares Number | $39,405,302 | $34,056,920 | $29,130,607 | $12,163,673 |
| Share Issued | $39,405,302 | $34,056,920 | $29,130,607 | $12,163,673 |
| Tangible Book Value | $26,404,000 | $21,458,000 | $9,611,000 | $13,185,000 |
| Invested Capital | $46,071,000 | $41,326,000 | $29,828,000 | $23,795,000 |
| Working Capital | $28,583,000 | $22,939,000 | $12,133,000 | $17,619,000 |
| Capital Lease Obligations | $3,382,000 | $4,795,000 | $4,902,000 | $6,674,000 |
| Total Capitalization | $45,807,000 | $41,058,000 | $29,584,000 | $21,661,000 |
| Additional Paid In Capital | $439,838,000 | $430,207,000 | $418,487,000 | $402,701,000 |
| Capital Stock | $4,000 | $3,000 | $3,000 | $1,000 |
| Common Stock | $4,000 | $3,000 | $3,000 | $1,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $0 | $429,000 | $475,000 | $2,600,000 |
| Long Term Capital Lease Obligation | $1,758,000 | $2,630,000 | $2,963,000 | $4,669,000 |
| Current Deferred Revenue | $356,000 | $143,000 | $289,000 | $1,797,000 |
| Current Capital Lease Obligation | $1,624,000 | $2,165,000 | $1,939,000 | $2,005,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,642,000 | $2,920,000 | $2,667,000 | $2,874,000 |
| Current Accrued Expenses | $1,695,000 | $3,355,000 | $4,482,000 | $4,828,000 |
| Goodwill | $921,000 | $921,000 | $921,000 | $921,000 |
| Net PPE | $7,849,000 | $10,344,000 | $11,018,000 | $8,605,000 |
| Accumulated Depreciation | $-10,721,000 | $-10,402,000 | $-8,804,000 | $-7,636,000 |
| Gross PPE | $18,570,000 | $20,746,000 | $19,822,000 | $16,241,000 |
| Leases | $1,567,000 | $1,562,000 | $1,423,000 | $1,256,000 |
| Other Properties | $3,946,000 | $5,366,000 | $5,423,000 | $7,218,000 |
| Machinery Furniture Equipment | $13,057,000 | $13,818,000 | $12,976,000 | $7,767,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,377,000 | $2,401,000 | $3,270,000 | $2,112,000 |
| Work In Process | $199,000 | $367,000 | $351,000 | $351,000 |
| Raw Materials | $1,848,000 | $3,010,000 | $2,250,000 | $3,351,000 |
| Other Short Term Investments | $14,286,000 | $5,940,000 | $1,952,000 | $11,390,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,201,000 | $3,191,000 | $-9,696,000 | $-17,210,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-659,000 | $4,202,000 | $-9,412,000 | $-16,929,000 |
| Cash Flow From Continuing Operating Activities | $-659,000 | $4,202,000 | $-9,412,000 | $-16,929,000 |
| Operating Gains Losses | $-210,000 | $-74,000 | $-320,000 | $-7,000 |
| Investing Activities | ||||
| Capital Expenditure | $-542,000 | $-1,011,000 | $-284,000 | $-281,000 |
| Investing Cash Flow | $-8,544,000 | $-4,866,000 | $-3,045,000 | $-2,396,000 |
| Cash Flow From Continuing Investing Activities | $-8,544,000 | $-4,866,000 | $-3,045,000 | $-2,396,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,816,000 | $10,181,000 | $14,861,000 | $30,016,000 |
| Financing Cash Flow | $4,252,000 | $7,348,000 | $11,342,000 | $16,150,000 |
| Cash Flow From Continuing Financing Activities | $4,252,000 | $7,348,000 | $11,342,000 | $16,150,000 |
| Net Other Financing Charges | $-2,371,000 | $-1,629,000 | $-5,000 | $-191,000 |
| Net Common Stock Issuance | $7,816,000 | $10,181,000 | $14,861,000 | $15,016,000 |
| Common Stock Issuance | $7,816,000 | $10,181,000 | $14,861,000 | $15,016,000 |
| Net Preferred Stock Issuance | - | - | $0 | $15,000,000 |
| Preferred Stock Issuance | - | - | $0 | $15,000,000 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-1,193,000 | $-1,204,000 | $-3,514,000 | $-13,675,000 |
| Interest Paid Supplemental Data | $772,000 | $847,000 | $1,209,000 | $1,470,000 |
| End Cash Position | $10,711,000 | $15,662,000 | $8,983,000 | $10,102,000 |
| Beginning Cash Position | $15,662,000 | $8,983,000 | $10,102,000 | $13,280,000 |
| Effect Of Exchange Rate Changes | $0 | $-5,000 | $-4,000 | $-3,000 |
| Changes In Cash | $-4,951,000 | $6,684,000 | $-1,115,000 | $-3,175,000 |
| Net Issuance Payments Of Debt | $-1,193,000 | $-1,204,000 | $-3,514,000 | $-13,675,000 |
| Net Short Term Debt Issuance | $-664,000 | $-646,000 | $-992,000 | $-1,443,000 |
| Short Term Debt Payments | $-664,000 | $-646,000 | $-992,000 | $-1,443,000 |
| Net Long Term Debt Issuance | $-529,000 | $-558,000 | $-2,522,000 | $-12,232,000 |
| Long Term Debt Payments | $-529,000 | $-558,000 | $-2,522,000 | $-12,232,000 |
| Net Investment Purchase And Sale | $-8,002,000 | $-3,855,000 | $9,600,000 | $-2,115,000 |
| Sale Of Investment | $16,200,000 | $2,003,000 | $15,301,000 | $19,182,000 |
| Purchase Of Investment | $-24,202,000 | $-5,858,000 | $-5,701,000 | $-21,297,000 |
| Net PPE Purchase And Sale | $-542,000 | $-1,011,000 | $-284,000 | $-281,000 |
| Purchase Of PPE | $-542,000 | $-1,011,000 | $-284,000 | $-281,000 |
| Change In Working Capital | $-1,613,000 | $-1,527,000 | $-7,244,000 | $-2,126,000 |
| Change In Other Working Capital | $-475,000 | $-46,000 | $-3,810,000 | $-3,826,000 |
| Change In Other Current Liabilities | $-1,662,000 | $-1,452,000 | $-1,465,000 | $1,113,000 |
| Change In Payables And Accrued Expense | $-2,549,000 | $-2,681,000 | $87,000 | $314,000 |
| Change In Accrued Expense | $-1,679,000 | $-1,034,000 | $-376,000 | - |
| Change In Payable | $-870,000 | $-1,647,000 | $463,000 | $314,000 |
| Change In Account Payable | $-870,000 | $-1,647,000 | $463,000 | $314,000 |
| Change In Prepaid Assets | $392,000 | $374,000 | $1,410,000 | $2,720,000 |
| Change In Inventory | $2,779,000 | $-332,000 | $1,176,000 | $-2,101,000 |
| Change In Receivables | $-98,000 | $2,610,000 | $-4,642,000 | $-346,000 |
| Changes In Account Receivables | $-98,000 | $2,610,000 | $-4,642,000 | $-346,000 |
| Other Non Cash Items | $2,471,000 | $2,386,000 | $3,117,000 | $2,382,000 |
| Stock Based Compensation | $1,816,000 | $1,292,000 | $932,000 | $315,000 |
| Provisionand Write Offof Assets | $-179,000 | $425,000 | $1,098,000 | $610,000 |
| Asset Impairment Charge | $178,000 | $0 | - | - |
| Depreciation Amortization Depletion | $2,192,000 | $2,180,000 | $1,444,000 | $576,000 |
| Depreciation And Amortization | $2,192,000 | $2,180,000 | $1,444,000 | $576,000 |
| Gain Loss On Investment Securities | $-267,000 | $-74,000 | $-321,000 | $-4,000 |
| Net Income From Continuing Operations | $-5,314,000 | $-480,000 | $-8,439,000 | $-18,679,000 |
| Net Business Purchase And Sale | - | $0 | $-12,361,000 | $0 |
| Purchase Of Business | - | $0 | $-12,361,000 | $0 |
| Common Stock Payments | - | - | - | $0 |
| Change In Other Current Assets | - | - | - | $2,720,000 |
| Depreciation | - | - | - | $2,589,000 |
| Net Foreign Currency Exchange Gain Loss | - | - | - | $-3,000 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-17